EMA Green Lights Hungarian Medicine Aimed To Ease Suffering Of Cancer Patients

The European Medicines Agency (EMA) has accepted Hungary-based pharmaceutical company Richter’s regulatory submission for its proposed biosimilar pegfilgrastim, a prescription medicine used in cancer patients to help with some of the side effects of their treatment. Richter’s self-developed medicine is administered to reduce the chance of infections related to a low white blood cell count in patients with … Continue reading EMA Green Lights Hungarian Medicine Aimed To Ease Suffering Of Cancer Patients